In 2024, the FDA approved biosimilar versions of Eylea, including the brand names Ahzantive, Enzeevu, Pavblu, Opuviz, and Yesafili. Anti-VEGF Treatments in the Pipeline In addition to injections, ...

An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.

Sam Chun Dang Pharm announced on the 5th that it has exported its ophthalmic disease treatment drug Eylea biosimilar, a copy of a biopharmaceutical, to overseas markets for the first time and will ...

Findings that U.S. companies can sue foreign rivals despite limited business operations in the country could dissuade drug ...

Alvotech and Advanz Pharma have inked a deal to expand their commercial partnership to cover three additional biosimilar candidates. The agreement covers the supply and commercialization in Europe ...

“As our data show, on average, patients paid more than 4 times as much out of pocket per month for Humira compared to Hadlima,” said Jon Martin, US Commercial Lead, Biosimilars and Established ...

Actemra reached its peak revenue of CHF 3.6 billion in 2021. Eydenzelt (Aflibercept) is a biosimilar pipeline of Eylea produced by Regeneron. Eylea is now at the peak of its commercial cycle.

Now may be a good time to initiate a small position on the dip. Regeneron is facing biosimilar competition for Eylea, one of its biggest growth drivers. In the first quarter, the company's revenue ...

Yuflyma is a high-concentration, citrate-free biosimilar to Humira, approved for multiple inflammatory indications including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis ...

A biosimilar is a closely engineered copy of an FDA-approved biologic. Unlike generic versions of drugs, biosimilars are not identical to the brand-name biologic they are duplicating. This is ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted ...